Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)
SM
MG
Overseen ByMonica Gruber
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Happify Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
This trial tests a digital therapeutic program for adults with depression or anxiety. Participants use the program on their devices for a few months, completing activities and assessments to help manage their mental health.
Research Team
RV
Roger Vilardaga, Ph.D.
Principal Investigator
Duke University
Eligibility Criteria
Inclusion Criteria
You have a computer or smartphone that can be used for the study, and you are willing to use it throughout the study.
You currently live in the United States.
You have been diagnosed with Major Depressive Disorder or Generalized Anxiety Disorder according to the DSM-5 criteria.
See 2 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Treatment
Participants use the HPDT-DA-013 digital therapeutic for 8-10 weeks, completing PHQ-9 and GAD-7 assessments, as well as safety and medication use questionnaires
8-10 weeks
Follow-up
Participants are monitored monthly for safety and effectiveness after treatment
12 months
Treatment Details
Interventions
- HPDT-DA-013
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Digital therapeuticExperimental Treatment1 Intervention
Use HPDT-DA-013 digital therapeutic for a period of 8-10 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Happify Inc.
Lead Sponsor
Trials
7
Recruited
21,600+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.